B. Riley Comments on Longboard Pharmaceuticals, Inc.'s Q2 2023 Earnings (NASDAQ:LBPH)
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Rating) – Research analysts at B. Riley issued their Q2 2023 earnings per share (EPS) estimates for Longboard Pharmaceuticals in a report issued on Wednesday, May 10th. B. Riley analyst K. Patel anticipates that the company will post earnings per share of ($0.55) for the quarter. B. Riley currently […]